Results 191 to 200 of about 54,740 (209)
Some of the next articles are maybe not open access.

The current state of the art and future trends in RAS-targeted cancer therapies

Nature Reviews Clinical Oncology, 2022
Kwok Kin Wong   +2 more
exaly  

Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment

Ca-A Cancer Journal for Clinicians, 2017
Misha Cohen   +2 more
exaly  

Evaluating complementary and alternative therapies for cancer patients

Ca-A Cancer Journal for Clinicians, 1999
B R Cassileth
exaly  

Integrative Oncology: Complementary Therapies for Pain, Anxiety, and Mood Disturbance

Ca-A Cancer Journal for Clinicians, 2005
Gary Deng, B R Cassileth
exaly  

Combining immunotherapy and targeted therapies in cancer treatment

Nature Reviews Cancer, 2012
Matthew Vanneman, Dranoff Glenn
exaly  

Targeted therapies: how personal should we go?

Nature Reviews Clinical Oncology, 2011
Salvatore Siena   +2 more
exaly  

Tumor control versus adverse events with targeted anticancer therapies

Nature Reviews Clinical Oncology, 2011
Dorothy Keefe, Keefe Dorothy M K
exaly  

An accelerated pathway for targeted cancer therapies

Nature Reviews Drug Discovery, 2011
Stephen Friend   +2 more
exaly  

New therapies and standard of care in oncology

Nature Reviews Clinical Oncology, 2011
George P Canellos, Devita Vincent T
exaly  

The Social Implications of Questionable Cancer Therapies

Ca-A Cancer Journal for Clinicians, 1989
B R Cassileth
exaly  

Home - About - Disclaimer - Privacy